US FDA approves Pfizer’s maternal RSV vaccine to protect infants
By Patrick Wingrove and Bhanvi Satija (Reuters) – The U.S. Food and Drug Administration on Monday approved Pfizer’s respiratory syncytial virus (RSV) vaccine for use …
pfizer’s
Pfizer’s updated COVID shot effective against ‘Eris’ variant in mice study
(Reuters) – Pfizer Inc said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the “Eris” subvariant …
U.S. FDA panel backs Pfizer’s RSV vaccine for protecting infants
(Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc’s experimental respiratory syncytial virus (RSV) …
US FDA approves Pfizer’s next-generation pneumococcal vaccine
(Reuters) – The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc’s next-generation vaccine to prevent pneumococcal disease in children aged six weeks to …
China Meheco to distribute Pfizer’s COVID treatment in China
HONG KONG (Reuters) – China Meheco Group Co Ltd said on Wednesday it signed an agreement with Pfizer Inc to import and distribute the U.S. …
Pfizer’s India arm posts profit jump on lower costs, price hikes
BENGALURU – Pfizer Ltd, the Indian arm of U.S. pharma giant Pfizer Inc, reported a rise in second-quarter profit on Friday, boosted by price hikes …
U.S. government to test Pfizer’s Paxlovid for long COVID
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug Paxlovid as the …
U.S. doctors reconsider Pfizer’s Paxlovid for lower-risk COVID patients
By Deena Beasley (Reuters) – Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients …
U.S. CDC recommends re-isolation if COVID recurs after taking Pfizer’s pill
(Reuters) – Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer’s drug Paxlovid should isolate again for five days, the U.S. Centers …
Evidence mounts for need to study Pfizer’s Paxlovid for long COVID – researchers say
By Julie Steenhuysen CHICAGO – Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus …
Pfizer’s vaccines head Kathrin Jansen to retire this year
(Reuters) – Pfizer Inc’s vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker’s COVID-19 shot, has decided to retire later this year. …
The case for testing Pfizer’s Paxlovid for treating long COVID
By Julie Steenhuysen CHICAGO – Reports of two patients who found relief from long COVID after taking Pfizer Inc’s antiviral Paxlovid, including a researcher who …
Pfizer’s new CFO David Denton to get $1.25 million as annual base salary
(Reuters) – Pfizer Inc’s newly appointed chief financial officer, David Denton, will get $1.25 million as annual base salary, the pharmaceutical giant said in a …
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
By Jonathan Stempel NEW YORK – A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing …
Pfizer’s COVID cash pile opens opportunities for deals
By Manas Mishra – Investors on Tuesday hope to learn Pfizer Inc’s plans for what could be a once-in-a-generation cash infusion from COVID-19 treatments and …
Explainer-How does Merck’s COVID-19 pill compare to Pfizer’s?
By Deena Beasley – Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are …